The case stemmed from an order passed on January 29 by the Commissioner of the Food and Drug Administration directing Dabur ...
Mumbai: After challenging the Food and Drug Administration's (FDA) directive to remove misleading claims from its toothpaste ...
ET Now on MSN1d
Dabur India Dividend, Q4 Results 2025 date: Hajmola maker's quarterly earnings announcement schedule OUTApart from the earnings report for January-March period of the financial year 2025, the Hajmola maker also informed that it ...
Dabur India Ltd submitted an affidavit before the Bombay High Court that it would no longer use 'anti-inflammatory', ...
In the exchange filing, Dabur India told the bourses that the company's Board of Directors will meet on Wednesday, 7th May 2025 to evaluate and approve unaudited standalone and consolidated financial ...
Demand for daily groceries and personal-care items has rebounded, driven by increased stocking of summer-focused products, ...
Mumbai: Dabur India Ltd has told the Bombay High Court that it will withdraw terms like "anti-inflammatory," "anti-bacterial, ...
Dabur India Ltd has told the Bombay High Court that it will withdraw terms like "anti-inflammatory," "anti-bacterial," and ...
Dabur Ltd can sell existing toothpaste stock with misleading claims until May 31, as permitted by Bombay High Court. Revised packaging for Dabur Meswak and Dabur Herb'l Anti-Bacterial Toothpaste ...
Online FMCG shopping in India has tripled, driven by the rise of quick commerce. FMCG companies are adapting with new ...
The Delhi High Court on Wednesday issued notice to the Food Safety and Standards Authority of India (FSSAI) in response to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback